Chemoinformaics analysis of 1-O-p-coumaroylglycerol
| Molecular Weight | 238.239 | nRot | 5 |
| Heavy Atom Molecular Weight | 224.127 | nRig | 8 |
| Exact Molecular Weight | 238.084 | nRing | 1 |
| Solubility: LogS | -0.816 | nHRing | 0 |
| Solubility: LogP | 1.172 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 33.3851 |
| nHD | 3 | BPOL | 16.6489 |
| QED | 0.507 |
| Synth | 2.598 |
| Natural Product Likeliness | 1.244 |
| NR-PPAR-gamma | 0.429 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.1 |
| HIA | 0.425 |
| CACO-2 | -5.101 |
| MDCK | 0.0000137 |
| BBB | 0.918 |
| PPB | 0.643293 |
| VDSS | 0.564 |
| FU | 0.471178 |
| CYP1A2-inh | 0.262 |
| CYP1A2-sub | 0.057 |
| CYP2c19-inh | 0.097 |
| CYP2c19-sub | 0.133 |
| CYP2c9-inh | 0.058 |
| CYP2c9-sub | 0.831 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.445 |
| CYP3a4-inh | 0.039 |
| CYP3a4-sub | 0.258 |
| CL | 9.276 |
| T12 | 0.93 |
| hERG | 0.034 |
| Ames | 0.101 |
| ROA | 0.73 |
| SkinSen | 0.924 |
| Carcinogencity | 0.482 |
| EI | 0.065 |
| Respiratory | 0.08 |
| NR-Aromatase | 0.031 |
| Antiviral | Yes |
| Prediction | 0.600229 |